ArticleJACC. Clinical electrophysiology2026
LMNA Deficiency Reveals a Role for SK3 Channel Dysfunction in Atrioventricular Block.
Article in JACC. Clinical electrophysiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundAtrioventricular block (AVB) is a conduction system disorder that, when severe, results in pacemaker implantation. LMNA mutations affecting the nuclear envelope proteins lamin A/C have been linked to AVB in patients, yet the underlying mechanisms remain largely unclear. The authors identified a nonsense LMNA-R225X mutation in a kindred that was associated with progressive AVB and atrial arrhythmias, followed by left ventricular dysfunction.
objectivesThe aims of this study were to elucidate the mechanisms underlying LMNA-R225X-mediated AVB and to identify novel therapeutic targets for its treatment.
methodsLMNA-R225X-knock-in mice were generated using clustered regularly interspaced short palindromic repeats/Cas9 technology. Cardiac phenotype was characterized using surface electrocardiography, telemetry electrocardiography, programmed electrical stimulation, and echocardiography. Histology, immunofluorescence staining, Ca
resultsHomozygous LMNA-R225X mice displayed bradycardia and first-degree AVB before death at 2 weeks. Similar to patients, R225X-heterozygous mice exhibited age-dependent progressive AVB, ranging from first to second degree, and increased susceptibility to atrial fibrillation, preceding the development of cardiomyopathy. Specific knockdown of LMNA in cardiac conduction system pacemaker cells was sufficient to induce AVB. RNA sequencing analysis of atrioventricular node tissue revealed up-regulation of genes related to fibrosis and cellular hypertrophy, accompanied by down-regulation of the small-conductance calcium-activated potassium channel type 3 (SK3) channel. Ca
conclusionsThese findings establish a direct role of LMNA deficiency in AVB and reveal the SK3 channel as a therapeutic target for the management of AVB.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.